0

Review of Advances in Uroprotective Agents for Cyclophosphamide- And Ifosfamide-induced Hemorrhagic Cystitis

Ethan L Matz, Michael H Hsieh

Urology. 2017 Feb;100:16-19.

PMID: 27566144

Abstract:

Cyclophosphamide and ifosfamide are widely used drugs for malignancies and rheumatologic conditions. One of the most significant adverse reactions to these drugs is hemorrhagic cystitis. Mesna is the most widely used uroprotective agent that acts to neutralize the caustic metabolite, acrolein, responsible for induction of hemorrhagic cystitis. However, mesna is not a perfect alternative, and studies since its discovery have investigated the use of alternative drugs and adjuncts to increase mesna's efficacy. This review details some of the recent work into novel uroprotective agents for drug-induced hemorrhagic cystitis.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP19767454-B Mesna Mesna 19767-45-4 Price
qrcode